EUVIMEDEUVIMED entdecken
Crossref

Role of the integrin-linked kinase/TGF-β/SMAD pathway in sitagliptin-mediated cardioprotective effects in a rat model of diabetic cardiomyopathy

Anfal F Bin Dayel iD, Asma S Alonazi iD, Nawal M Alrasheed, Maha A Alamin, Wedad S Sarawi, Abeer O Alharbi, Nahla'a A Alabbad, Danah A Albuaijan, Dareen N Alassiri, Alanoud F Aljarbua, Fatimah K Almusaytir, Nouf M Alrasheed

Journal of Pharmacy and Pharmacology · 2024

DOI: 10.1093/jpp/rgad111 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2024. Verfasst von Anfal F Bin Dayel und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia. Hauptthemen laut MEDLINE: Diabetic Cardiomyopathies, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Ministry of Education in Saudi Arabia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Diabetic cardiomyopathy is a known complication of diabetes mellitus. Herein, we aimed to determine whether glycemic control mediated by sitagliptin, a dipeptidyl peptidase-4 inhibitor, can ameliorate diabetic myocardial abnormalities by modulating TGF-β signaling via the SMAD and integrin-linked kinase (ILK) pathways.

Methods

Four groups of male Wistar albino rats were used, with six rats in each group. Two nondiabetic and two diabetic (produced by a single intraperitoneal dose of streptozotocin (55 mg/kg)) groups were administered either normal saline or sitagliptin (100 mg/kg) orally for 6 weeks. Subsequently, HW/BW ratios and cardiac enzymes were assessed, along with a histological examination of cardiac tissues. Levels of TGF-β, collagen I, p-SMAD2/3, TNF-α, MMP-9, and ILK were detected.

Results

Compared with the diabetic control group, sitagliptin-treated diabetic rats exhibited considerably reduced HW/BW ratios and troponin I and creatine kinase-MB levels, with improvements in histopathological changes in cardiac tissues. TGF-β, collagen I, p-SMAD2/3, TNF-α, and MMP-9 levels were significantly decreased in the sitagliptin-treated diabetic group, whereas ILK was elevated following sitagliptin treatment.

Conclusion

Sitagliptin could afford cardioprotective effects for the first time by altering ILK-associated TGF-β/SMAD signaling pathways. Thus, sitagliptin may be a promising therapeutic target for the prevention of diabetic cardiomyopathy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic CardiomyopathiesDiabetes Mellitus, ExperimentalRatsMaleAnimalsSitagliptin PhosphateMatrix Metalloproteinase 9Transforming Growth Factor betaRats, WistarTumor Necrosis Factor-alphaCollagenScaffold Protein ILK

Stichwörter der Autor:innen

diabetic cardiomyopathydipeptidyl peptidase-4 inhibitorintegrin-linked-kinasesitagliptin

Substanzen

Sitagliptin PhosphateMatrix Metalloproteinase 9Transforming Growth Factor betaTumor Necrosis Factor-alphaCollagenScaffold Protein ILK

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
  • College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.

ORCID-Profile: Anfal F Bin Dayel, Asma S Alonazi

Förderung

  • Ministry of Education in Saudi Arabia

Zitieren

APA

Bin Dayel, A. F., Alonazi, A. S., Alrasheed, N. M., Alamin, M. A., Sarawi, W. S., Alharbi, A. O., Alabbad, N. A., Albuaijan, D. A., Alassiri, D. N., Aljarbua, A. F., Almusaytir, F. K., & Alrasheed, N. M. (2024). Role of the integrin-linked kinase/TGF-β/SMAD pathway in sitagliptin-mediated cardioprotective effects in a rat model of diabetic cardiomyopathy. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgad111

Vancouver

Bin Dayel AF, Alonazi AS, Alrasheed NM, Alamin MA, Sarawi WS, Alharbi AO, et al. Role of the integrin-linked kinase/TGF-β/SMAD pathway in sitagliptin-mediated cardioprotective effects in a rat model of diabetic cardiomyopathy. Journal of Pharmacy and Pharmacology. 2024. doi:10.1093/jpp/rgad111

BibTeX
@article{BinDayel2024,
  author = {Bin Dayel, Anfal F and Alonazi, Asma S and Alrasheed, Nawal M and Alamin, Maha A and Sarawi, Wedad S and Alharbi, Abeer O and Alabbad, Nahla'a A and Albuaijan, Danah A and Alassiri, Dareen N and Aljarbua, Alanoud F and Almusaytir, Fatimah K and Alrasheed, Nouf M},
  title = {Role of the integrin-linked kinase/TGF-β/SMAD pathway in sitagliptin-mediated cardioprotective effects in a rat model of diabetic cardiomyopathy},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2024},
  doi = {10.1093/jpp/rgad111}
}
Kostenlos starten →